Stay updated on Cabozantinib & 13-cisRA in Children Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib & 13-cisRA in Children Clinical Trial page.

Latest updates to the Cabozantinib & 13-cisRA in Children Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedMajor update: adds a government-status notice and a new version tag (v3.2.0); removes the old version tag (v3.1.0).SummaryDifference4%
- Check23 days agoChange DetectedUpdated revision tag to v3.1.0 and added new contact information; removed the old revision tag v3.0.2. No changes to core content or pricing noted.SummaryDifference0.1%
- Check37 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.2%
- Check51 days agoChange DetectedThe web page has been updated to include new drug information for Cabozantinib and Isotretinoin, along with related topics on cancer and immunotherapy, while removing outdated drug information and location details.SummaryDifference4%
- Check65 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Cabozantinib & 13-cisRA in Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib & 13-cisRA in Children Clinical Trial page.